🕵️ Petros Pharmaceuticals, Inc. ($PTPI)
SEC insider & ownership activity, last 12 months · CIK 1815903 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. One red-flag 8-K in the window: Delisting notice (3.01), Nov 3, 2025.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Iroquois Capital Management, LLC | 10.0% | 13G | Feb 17, 2026 | filing ↗ | |
| Richard Abbe | 10.0% | 13G | Feb 17, 2026 | filing ↗ | |
| Kimberly Page | 10.0% | 13G | Feb 17, 2026 | filing ↗ | |
| Ayrton Capital LLC | 6.2% | 13G | Feb 13, 2025 | filing ↗ | |
| ALTO Opportunity Master Fund, SPC - Segregated Master Portfolio B | 6.2% | 13G | Feb 13, 2025 | filing ↗ | |
| Waqas Khatri | 6.2% | 13G | Feb 13, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jun 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 18, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 5, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 1, 2026 | filing ↗ |
| Delisting notice (3.01) | Nov 3, 2025 | filing ↗ |
| Auditor change (4.01) | Aug 29, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 29, 2025 | filing ↗ |